<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04480320</url>
  </required_header>
  <id_info>
    <org_study_id>K-2020-085-01</org_study_id>
    <nct_id>NCT04480320</nct_id>
  </id_info>
  <brief_title>Sonography-guided Pericapsular Never Group Block for Hip Arthroplasty</brief_title>
  <acronym>QUASH</acronym>
  <official_title>Sonography-guided Pericapsular Nerve Group Block for Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangzhou First People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangzhou First People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigator will examine the efficacy of Pericapsular nerve group (PENG)
      block in hip arthroplasty as a post-operative pain management technique, study the analgesia,
      opioid-sparing effects and motor-blocking effects of the PENG block
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PENG Block group (PG) will receive 0.5%Ropivacaine in 20 ml of saline. Sham Block group (SG)
      will receive 20 ml of saline Patient will be sedated with IV midazolam before nerve block.
      After peripheral nerve block ,general anesthesia will be conducted using sufentanyl, propofol
      and rocuronium for induction and propofol and sevoflurane for maintenance. Tests will be
      operated after procedureï¼Œand recorded up to 48 hours after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 18, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Highest VAS score in recovery room</measure>
    <time_frame>before recovery room discharge(up to 2 hours after surgery end)</time_frame>
    <description>Highest VAS score reported in recovery room,patient will be asked questions to measure the highest VAS score experienced in the recovery room before discharge. If the patient had a unexpected long stay at recovery room, the question will be asked at the time point &quot;2 hours after surgery end&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS at rest</measure>
    <time_frame>day0 ,day1 ,day2</time_frame>
    <description>VAS pain score while patient at rest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>highest VAS at period</measure>
    <time_frame>day0 ,day1 ,day2</time_frame>
    <description>highest VAS reported at follow up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quadriceps strength</measure>
    <time_frame>day0 , day1 ,day2</time_frame>
    <description>Measure quadriceps strength peak value at different time point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total opioid consumption</measure>
    <time_frame>up to 2 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PONV rate</measure>
    <time_frame>day0 ,day1 ,day2</time_frame>
    <description>postoperative nausea and vomit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fall incident happened</measure>
    <time_frame>up to 2 days after surgery</time_frame>
    <description>Record the fall incident happened,fall is defined as patinent accidently fall to the ground.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nerve block range</measure>
    <time_frame>day0 , before discharge from PACU(up to 2 hours after surgery end)</time_frame>
    <description>A cotton yarn with ethanol will be put on both the surgical and nonsurgical leg to evaluate the cold sensation lost after nerve block.Skin sensation lost will be tested at lateral thigh,medial thigh,front thigh and lateral claf</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">71</enrollment>
  <condition>Arthroplasty</condition>
  <condition>Nerve Block</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Pericapsular nerve group block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pericapsular nerve group block</intervention_name>
    <description>Branches of both the FN and ON provide innervation to the anterior hip capsule. High and low branches of FN provided the majority of innervation to the lateral and superomedial hip capsule. The AON innervates the medial capsule.Both of the nerve close to the periosteum between the iliopubic eminence and AIIS ,by using ultrasound guided technique,these sites can be potential bony landmarks provid approch to the nerve group.</description>
    <arm_group_label>Pericapsular nerve group block</arm_group_label>
    <arm_group_label>Saline placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for hip arthroplasty

        Exclusion Criteria:

          -  allergy to local anesthetics

          -  infection at the injection site

          -  patients receiving opioids for chronic analgesic therapy

          -  other lower limb neuropathies

          -  inability to comprehend visual analog scale (VAS)

          -  preexist cognitive dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Guangzhou First Municipal People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510180</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 2, 2020</study_first_submitted>
  <study_first_submitted_qc>July 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2020</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangzhou First People's Hospital</investigator_affiliation>
    <investigator_full_name>Xiangcai Ruan, MD, PhD, Vice-Director in Dept Anesth &amp; Pain</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Pericapsular Nerve Group</keyword>
  <keyword>PENG</keyword>
  <keyword>hip arthroplasty</keyword>
  <keyword>Postoperative analgesia</keyword>
  <keyword>quadriceps strength</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

